SUBSCRIBE
3 minutes
Edinburgh-based Censo Biotechnologiesand Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterization services, have announced a merger and subsequent £3.8 million funding round. The new entity will become a leading provider of product and service s
